Retroviral envelope glycoprotein (Env) is essential for the specific recognition of the host cell and the initial phase of infection. As reported for human immunodeficiency virus (HIV), the recruitment of Env into a retroviral membrane envelope is mediated through its interaction with a Gag polyprotein precursor of structural proteins. This interaction, occurring between the matrix domain (MA) of Gag and the cytoplasmic tail (CT) of the transmembrane domain of Env, takes place at the host cell plasma membrane. To determine whether the MA of Mason-Pfizer monkey virus (M-PMV) also interacts directly with the CT of Env, we mimicked the in vivo conditions in an in vitro experiment by using a CT in its physiological trimeric conformation mediated by the trimerization motif of the GCN4 yeast transcription factor. The MA protein was used at the concentration shifting the equilibrium to its trimeric form. The direct interaction between MA and CT was confirmed by a pulldown assay. Through the combination of nuclear magnetic resonance (NMR) spectroscopy and protein cross-linking followed by mass spectrometry analysis, the residues involved in mutual interactions were determined. NMR has shown that the C terminus of the CT is bound to the C-terminal part of MA. In addition, protein cross-linking confirmed the close proximity of the N-terminal part of CT and the N terminus of MA, which is enabled in vivo by their location at the membrane. These results are in agreement with the previously determined orientation of MA on the membrane and support the already observed mechanisms of M-PMV virus-like particle transport and budding.IMPORTANCE By a combination of nuclear magnetic resonance (NMR) and mass spectroscopy of cross-linked peptides, we show that in contrast to human immunodeficiency virus type 1 (HIV-1), the C-terminal residues of the unstructured cytoplasmic tail of Mason-Pfizer monkey virus (M-PMV) Env interact with the matrix domain (MA). Based on biochemical data and molecular modeling, we propose that individual cytoplasmic tail (CT) monomers of a trimeric complex bind MA molecules belonging to different neighboring trimers, which may stabilize the MA orientation at the membrane by the formation of a membrane-bound net of interlinked Gag and CT trimers. This also corresponds with the concept that the membrane-bound MA of Gag recruits Env through interaction with the full-length CT, while CT truncation during maturation attenuates the interaction to facilitate uncoating. We propose a model suggesting different arrangements of MA-CT complexes between a D-type and C-type retroviruses with short and long CTs, respectively.

Department of Biochemistry and Microbiology University of Chemistry and Technology Prague Prague Czech Republic

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic

Laboratory of NMR Spectroscopy University of Chemistry and Technology Prague Prague Czech Republic

Zobrazit více v PubMed

Rhee SS, Hunter E. 1990. A single amino-acid substitution within the matrix protein of a type-D retrovirus converts its morphogenesis to that of a type-C retrovirus. Cell 63:77–86. doi:10.1016/0092-8674(90)90289-Q. PubMed DOI

Sfakianos JN, Hunter E. 2003. M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic 4:671–680. doi:10.1034/j.1600-0854.2003.00126.x. PubMed DOI

Schur FKM, Hagen WJH, Rumlova M, Ruml T, Muller B, Krausslich HG, Briggs JAG. 2015. Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution. Nature 517:505–508. doi:10.1038/nature13838. PubMed DOI

Proksova PG, Lipov J, Zelenka J, Hunter E, Langerova H, Rumlova M, Ruml T. 2018. Mason-Pfizer monkey virus envelope glycoprotein cycling and its vesicular co-transport with immature particles. Viruses 10:575. doi:10.3390/v10100575. PubMed DOI PMC

Pereira LE, Clark J, Grznarova P, Wen X, LaCasse R, Ruml T, Spearman P, Hunter E. 2014. Direct evidence for intracellular anterograde co-transport of M-PMV Gag and Env on microtubules. Virology 449:109–119. doi:10.1016/j.virol.2013.11.006. PubMed DOI PMC

Song C, Dubay SR, Hunter E. 2003. A tyrosine motif in the cytoplasmic domain of Mason-Pfizer monkey virus is essential for the incorporation of glycoprotein into virions. J Virol 77:5192–5200. doi:10.1128/jvi.77.9.5192-5200.2003. PubMed DOI PMC

Cosson P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 15:5783–5788. doi:10.1002/j.1460-2075.1996.tb00964.x. PubMed DOI PMC

Vincent MJ, Melsen LR, Martin AS, Compans RW. 1999. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins. J Virol 73:8138–8144. doi:10.1128/JVI.73.10.8138-8144.1999. PubMed DOI PMC

Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A 85:9580–9584. doi:10.1073/pnas.85.24.9580. PubMed DOI PMC

Castillo-Menendez LR, Witt K, Espy N, Princiotto A, Madani N, Pacheco B, Finzi A, Sodroski J. 2018. Comparison of uncleaved and mature human immunodeficiency virus membrane envelope glycoprotein trimers. J Virol 92:e00277-18. doi:10.1128/JVI.00277-18. PubMed DOI PMC

Yang X, Kurteva S, Ren X, Lee S, Sodroski J. 2005. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J Virol 79:12132–12147. doi:10.1128/JVI.79.19.12132-12147.2005. PubMed DOI PMC

Cao J, Bergeron L, Helseth E, Thali M, Repke H, Sodroski J. 1993. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol 67:2747–2755. doi:10.1128/JVI.67.5.2747-2755.1993. PubMed DOI PMC

Kirschman J, Qi M, Ding L, Hammonds J, Dienger-Stambaugh K, Wang JJ, Lapierre LA, Goldenring JR, Spearman P. 2017. HIV-1 envelope glycoprotein trafficking through the endosomal recycling compartment is required for particle incorporation. J Virol 92:e01893-17. doi:10.1128/JVI.01893-17. PubMed DOI PMC

Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI. 1996. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A 93:3099–3104. doi:10.1073/pnas.93.7.3099. PubMed DOI PMC

Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, Sundquist WI. 1994. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol 244:198–223. doi:10.1006/jmbi.1994.1719. PubMed DOI

Murakami T, Freed EO. 2000. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol 74:3548–3554. doi:10.1128/jvi.74.8.3548-3554.2000. PubMed DOI PMC

Freed EO, Martin MA. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 69:1984–1989. doi:10.1128/JVI.69.3.1984-1989.1995. PubMed DOI PMC

Mammano F, Kondo E, Sodroski J, Bukovsky A, Gottlinger HG. 1995. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol 69:3824–3830. doi:10.1128/JVI.69.6.3824-3830.1995. PubMed DOI PMC

Tedbury PR, Ablan SD, Freed EO. 2013. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog 9:e1003739. doi:10.1371/journal.ppat.1003739. PubMed DOI PMC

Tedbury PR, Novikova M, Ablan SD, Freed EO. 2016. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation. Proc Natl Acad Sci U S A 113:e182–e190. doi:10.1073/pnas.1516618113. PubMed DOI PMC

Tedbury PR, Freed EO. 2015. The cytoplasmic tail of retroviral envelope glycoproteins. Prog Mol Biol Transl Sci 129:253–284. doi:10.1016/bs.pmbts.2014.10.009. PubMed DOI PMC

Brody BA, Rhee SS, Sommerfelt MA, Hunter E. 1992. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc Natl Acad Sci U S A 89:3443–3447. doi:10.1073/pnas.89.8.3443. PubMed DOI PMC

Green N, Shinnick TM, Witte O, Ponticelli A, Sutcliffe JG, Lerner RA. 1981. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc Natl Acad Sci U S A 78:6023–6027. doi:10.1073/pnas.78.10.6023. PubMed DOI PMC

Aguilar HC, Anderson WF, Cannon PM. 2003. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R peptide. J Virol 77:1281–1291. doi:10.1128/jvi.77.2.1281-1291.2003. PubMed DOI PMC

Song YE, Olinger GY, Janaka SK, Johnson MC. 2019. Sequence determinants in gammaretroviral Env cytoplasmic tails dictate virus-specific pseudotyping compatibility. J Virol 93:e02172-18. doi:10.1128/JVI.02172-18. PubMed DOI PMC

Aydin H, Cook JD, Lee JE. 2014. Crystal structures of beta- and gammaretrovirus fusion proteins reveal a role for electrostatic stapling in viral entry. J Virol 88:143–153. doi:10.1128/JVI.02023-13. PubMed DOI PMC

Murphy RE, Samal AB, Vlach J, Saad JS. 2017. Solution structure and membrane interaction of the cytoplasmic tail of HIV-1 gp41 protein. Structure 25:1708.e5–1718.e5. doi:10.1016/j.str.2017.09.010. PubMed DOI PMC

Prchal J, Junkova P, Strmiskova M, Lipov J, Hynek R, Ruml T, Hrabal R. 2011. Expression and purification of myristoylated matrix protein of Mason-Pfizer monkey virus for NMR and MS measurements. Protein Expr Purif 79:122–127. doi:10.1016/j.pep.2011.05.010. PubMed DOI PMC

Merkley ED, Rysavy S, Kahraman A, Hafen RP, Daggett V, Adkins JN. 2014. Distance restraints from crosslinking mass spectrometry: mining a molecular dynamics simulation database to evaluate lysine-lysine distances. Protein Sci 23:747–759. doi:10.1002/pro.2458. PubMed DOI PMC

Vlach J, Srb P, Prchal J, Grocky M, Lang J, Ruml T, Hrabal R. 2009. Nonmyristoylated matrix protein from the Mason-Pfizer monkey virus forms oligomers. J Mol Biol 390:967–980. doi:10.1016/j.jmb.2009.05.063. PubMed DOI

Morikawa Y, Zhang WH, Hockley DJ, Nermut MV, Jones IM. 1998. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J Virol 72:7659–7663. doi:10.1128/JVI.72.9.7659-7663.1998. PubMed DOI PMC

Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF. 2004. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci U S A 101:517–522. doi:10.1073/pnas.0305665101. PubMed DOI PMC

Junkova P, Prchal J, Spiwok V, Pleskot R, Kadlec J, Krasny L, Hynek R, Hrabal R, Ruml T. 2016. Molecular aspects of the interaction between Mason-Pfizer monkey virus matrix protein and artificial phospholipid membrane. Proteins 84:1717–1727. doi:10.1002/prot.25156. PubMed DOI

Murakami T. 2008. Roles of the interactions between Env and Gag proteins in the HIV-1 replication cycle. Microbiol Immunol 52:287–295. doi:10.1111/j.1348-0421.2008.00008.x. PubMed DOI

Steckbeck JD, Craigo JK, Barnes CO, Montelaro RC. 2011. Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication. J Biol Chem 286:27156–27166. doi:10.1074/jbc.M111.258855. PubMed DOI PMC

Brody BA, Rhee SS, Hunter E. 1994. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J Virol 68:4620–4627. doi:10.1128/JVI.68.7.4620-4627.1994. PubMed DOI PMC

Hermida-Matsumoto L, Resh MD. 1999. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J Virol 73:1902–1908. doi:10.1128/JVI.73.3.1902-1908.1999. PubMed DOI PMC

Song C, Micoli K, Bauerova H, Pichova I, Hunter E. 2005. Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions. J Virol 79:11559–11568. doi:10.1128/JVI.79.18.11559-11568.2005. PubMed DOI PMC

Prchal J, Srb P, Hunter E, Ruml T, Hrabal R. 2012. The structure of myristoylated Mason-Pfizer monkey virus matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in its membrane binding. J Mol Biol 423:427–438. doi:10.1016/j.jmb.2012.07.021. PubMed DOI PMC

Alfadhli A, Mack A, Ritchie C, Cylinder I, Harper L, Tedbury PR, Freed EO, Barklis E. 2016. Trimer enhancement mutation effects on HIV-1 matrix protein binding activities. J Virol 90:5657–5664. doi:10.1128/JVI.00509-16. PubMed DOI PMC

Alfadhli A, Staubus AO, Tedbury PR, Novikova M, Freed EO, Barklis E. 2019. Analysis of HIV-1 matrix-envelope cytoplasmic tail interactions. J Virol 93:e01079-19. doi:10.1128/JVI.01079-19. PubMed DOI PMC

Leavell MD, Novak P, Behrens CR, Schoeniger JS, Kruppa GH. 2004. Strategy for selective chemical cross-linking of tyrosine and lysine residues. J Am Soc Mass Spectrom 15:1604–1611. doi:10.1016/j.jasms.2004.07.018. PubMed DOI

Swaim CL, Smith JB, Smith DL. 2004. Unexpected products from the reaction of the synthetic cross-linker 3,3′-dithiobis(sulfosuccinimidyl propionate), DTSSP with peptides. J Am Soc Mass Spectrom 15:736–749. doi:10.1016/j.jasms.2004.01.011. PubMed DOI

Kalkhof S, Sinz A. 2008. Chances and pitfalls of chemical cross-linking with amine-reactive N-hydroxysuccinimide esters. Anal Bioanal Chem 392:305–312. doi:10.1007/s00216-008-2231-5. PubMed DOI

Madler S, Bich C, Touboul D, Zenobi R. 2009. Chemical cross-linking with NHS esters: a systematic study on amino acid reactivities. J Mass Spectrom 44:694–706. doi:10.1002/jms.1544. PubMed DOI

Hunter E, Swanstrom R. 1990. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 157:187–253. doi:10.1007/978-3-642-75218-6_7. PubMed DOI

Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A. 2003. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (review). Mol Membr Biol 20:243–254. doi:10.1080/0968768031000104944. PubMed DOI

Goddard TD, Kneller DG. 2002. SPARKY 3. University of California, San Francisco, San Francisco, CA: https://iop.vast.ac.vn/theor/conferences/smp/1st/kaminuma/UCSFComputerGraphicsLab/index-16.htm.

Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED. 2005. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59:687–696. doi:10.1002/prot.20449. PubMed DOI

Gotze M, Pettelkau J, Schaks S, Bosse K, Ihling CH, Krauth F, Fritzsche R, Kuhn U, Sinz A. 2012. StavroX–a software for analyzing crosslinked products in protein interaction studies. J Am Soc Mass Spectrom 23:76–87. doi:10.1007/s13361-011-0261-2. PubMed DOI

van Zundert GCP, Rodrigues J, Trellet M, Schmitz C, Kastritis PL, Karaca E, Melquiond ASJ, van Dijk M, de Vries SJ, Bonvin A. 2016. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol 428:720–725. doi:10.1016/j.jmb.2015.09.014. PubMed DOI

Schwieters CD, Kuszewski JJ, Tjandra N, Marius Clore G. 2003. The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160:65–73. doi:10.1016/S1090-7807(02)00014-9. PubMed DOI